RÉSUMÉ
Skeletal muscle, which is predominantly constituted by multinucleated muscle fibers, plays a pivotal role in sustaining bodily movements and energy metabolism. Myoblasts, which serve as precursor cells for differentiation and fusion into muscle fibers, are of critical importance in the exploration of the functional genes associated with embryonic muscle development. However, the in vitro proliferation of primary myoblasts is inherently constrained. In this study, we achieved a significant breakthrough by successfully establishing a chicken myoblast cell line through the introduction of the exogenous chicken telomerase reverse transcriptase (chTERT) gene, followed by rigorous G418-mediated pressure screening. This newly developed cell line, which was designated as chTERT-myoblasts, closely resembled primary myoblasts in terms of morphology and exhibited remarkable stability in culture for at least 20 generations of population doublings without undergoing malignant transformation. In addition, we conducted an exhaustive analysis that encompassed cellular proliferation, differentiation, and transfection characteristics. Our findings revealed that the chTERT-myoblasts had the ability to proliferate, differentiate, and transfect after multiple rounds of population doublings. This achievement not only furnished a valuable source of homogeneous avian cell material for investigating embryonic muscle development, but also provided valuable insights and methodologies for establishing primary cell lines.
Sujet(s)
Différenciation cellulaire , Prolifération cellulaire , Poulets , Myoblastes , Telomerase , Animaux , Myoblastes/cytologie , Myoblastes/métabolisme , Lignée cellulaire , Telomerase/métabolisme , Telomerase/génétique , Développement musculaire/génétique , Techniques de culture cellulaire/méthodes , Transfection , Embryon de pouletRÉSUMÉ
As the largest organ in the human body, skeletal muscle is essential for breathing support, movement initiation, and maintenance homeostasis. It has been shown that programmed cell death (PCD), which includes autophagy, apoptosis, and necrosis, is essential for the development of skeletal muscle. A novel form of PCD called ferroptosis is still poorly understood in relation to skeletal muscle. In this study, we observed that the activation of ferroptosis significantly impeded the differentiation of C2C12 myoblasts into myotubes and concurrently suppressed the expression of OTUB1, a crucial deubiquitinating enzyme. OTUB1-silenced C2C12 mouse myoblasts were used to investigate the function of OTUB1 in ferroptosis. The results show that OTUB1 knockdown in vitro significantly increased C2C12 ferroptosis and inhibited myogenesis. Interestingly, the induction of ferroptosis resulting from OTUB1 knockdown was concomitant with the activation of autophagy. Furthermore, OTUB1 interacted with the P62 protein and stabilized its expression by deubiquitinating it, thereby inhibiting autophagy-dependent ferroptosis and promoting myogenesis. All of these findings demonstrate the critical role that OTUB1 plays in controlling ferroptosis, and we suggest that focusing on the OTUB1-P62 axis may be a useful tactic in the treatment and prevention of disorders involving the skeletal muscle.
Sujet(s)
Autophagie , Différenciation cellulaire , Cysteine endopeptidases , Ferroptose , Développement musculaire , Fibres musculaires squelettiques , Myoblastes , Animaux , Souris , Fibres musculaires squelettiques/métabolisme , Ferroptose/génétique , Cysteine endopeptidases/métabolisme , Cysteine endopeptidases/génétique , Myoblastes/métabolisme , Myoblastes/cytologie , Lignée cellulaire , Enzymes de désubiquitinylation/métabolisme , Enzymes de désubiquitinylation/génétique , Ubiquitination , Humains , Séquestosome-1/métabolisme , Séquestosome-1/génétiqueRÉSUMÉ
Despite the demonstrated importance of DNA G-quadruplexes (G4s) in health and disease, technologies to readily manipulate specific G4 folding for functional analysis and therapeutic purposes are lacking. Here we employ G4-stabilizing protein/ligand in conjunction with CRISPR to selectively facilitate single or multiple targeted G4 folding within specific genomic loci. We demonstrate that fusion of nucleolin with a catalytically inactive Cas9 can specifically stabilize G4s in the promoter of oncogene MYC and muscle-associated gene Itga7 as well as telomere G4s, leading to cell proliferation arrest, inhibition of myoblast differentiation and cell senescence, respectively. Furthermore, CRISPR can confer intra-G4 selectivity to G4-binding compounds pyridodicarboxamide and pyridostatin. Compared with traditional G4 ligands, CRISPR-guided biotin-conjugated pyridodicarboxamide enables a more precise investigation into the biological functionality of de novo G4s. Our study provides insights that will enhance understanding of G4 functions and therapeutic interventions.
Sujet(s)
Systèmes CRISPR-Cas , G-quadruplexes , , Protéines de liaison à l'ARN , Humains , Ligands , Protéines de liaison à l'ARN/métabolisme , Protéines de liaison à l'ARN/génétique , Phosphoprotéines/métabolisme , Phosphoprotéines/génétique , Acides picoliniques/pharmacologie , Acides picoliniques/composition chimique , Prolifération cellulaire/effets des médicaments et des substances chimiques , Différenciation cellulaire/effets des médicaments et des substances chimiques , Animaux , Vieillissement de la cellule/effets des médicaments et des substances chimiques , Vieillissement de la cellule/génétique , Protéine-9 associée à CRISPR/métabolisme , Protéine-9 associée à CRISPR/génétique , Régions promotrices (génétique) , Télomère/métabolisme , Télomère/génétique , Protéines proto-oncogènes c-myc/génétique , Protéines proto-oncogènes c-myc/métabolisme , Pyridines/pharmacologie , Pyridines/composition chimique , ADN/métabolisme , ADN/génétique , Souris , Clustered regularly interspaced short palindromic repeats , Cellules HEK293 , Myoblastes/métabolisme , Myoblastes/cytologie , AminoquinoléinesRÉSUMÉ
Ferroptosis adversely affects the viability, differentiation, and metabolic integrity of C2C12 myoblasts, contributing to the decline in skeletal muscle health. The intricate mechanisms behind this process are not fully understood. In this study, we induced ferroptosis in myoblasts using targeted inducers and found a marked decrease in specific redox metabolites, particularly taurine. Taurine supplementation effectively reversed the deleterious effects of ferroptosis, significantly increased cellular glutathione levels, reduced MDA and ROS levels, and rejuvenated impaired myogenic differentiation. Furthermore, taurine downregulated HO-1 expression and decreased intracellular Fe2+ levels, thereby stabilizing the labile iron pool. Using NMR metabolomic analysis, we observed that taurine profoundly promoted glycerophospholipid metabolism, which is critical for cell membrane repair, and enhanced mitochondrial bioenergetics, thereby increasing the energy reserves essential for muscle satellite cell regeneration. These results suggest that taurine is a potent ferroptosis inhibitor that attenuates key drivers of this process, strengthens oxidative defenses, and improves redox homeostasis. This combined effect protects cells from ferroptosis-induced damage. This study highlights the potential of taurine as a valuable ferroptosis inhibitor that protects skeletal muscle from ferroptosis-induced damage and provides a basis for therapeutic strategies to rejuvenate and facilitate the regeneration of aging skeletal muscle.
Sujet(s)
Ferroptose , Homéostasie , Fer , Myoblastes , Oxydoréduction , Taurine , Taurine/pharmacologie , Ferroptose/effets des médicaments et des substances chimiques , Oxydoréduction/effets des médicaments et des substances chimiques , Myoblastes/effets des médicaments et des substances chimiques , Myoblastes/métabolisme , Myoblastes/cytologie , Fer/métabolisme , Animaux , Souris , Homéostasie/effets des médicaments et des substances chimiques , Lignée cellulaire , Espèces réactives de l'oxygène/métabolisme , Différenciation cellulaire/effets des médicaments et des substances chimiques , Muscles squelettiques/effets des médicaments et des substances chimiques , Muscles squelettiques/métabolisme , Glutathion/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Glycérophospholipides/métabolismeRÉSUMÉ
Long noncoding RNAs (lncRNAs) participate in regulating skeletal muscle development. However, little is known about their role in regulating chicken myogenesis. In this study, we identified a novel lncRNA, lncMPD2, through transcriptome sequencing of chicken myoblasts at different developmental stages. Functionally, gain- and loss-of-function experiments showed that lncMPD2 inhibited myoblast proliferation and differentiation. Mechanistically, lncMPD2 directly bound to miR-34a-5p, and miR-34a-5p promoted myoblasts proliferation and differentiation and inhibited the mRNA and protein expression of its target gene THBS1. THBS1 inhibited myoblast proliferation and differentiation in vitro and delayed muscle regeneration in vivo. Furthermore, rescue experiments showed that lncMPD2 counteracted the inhibitory effects of miR-34a-5p on THBS1 and myogenesis-related gene mRNA and protein expression. In conclusion, lncMPD2 regulates the miR-34a-5p/THBS1 axis to inhibit the proliferation and differentiation of myoblasts and skeletal muscle regeneration. This study provides more insight into the molecular regulatory network of skeletal muscle development, identifying novel potential biomarkers for improving chicken quality and increasing chicken yield. In addition, this study provides a potential goal for breeding strategies that minimize muscle damage in chickens.
Sujet(s)
Différenciation cellulaire , Prolifération cellulaire , Poulets , microARN , Développement musculaire , Myoblastes , ARN long non codant , Développement musculaire/génétique , ARN long non codant/génétique , Animaux , microARN/génétique , Différenciation cellulaire/génétique , Myoblastes/métabolisme , Myoblastes/cytologie , Muscles squelettiques/métabolisme , Régénération/génétiqueRÉSUMÉ
The skeletal muscle is the major muscle tissue in animals, and its production is subject to a complex and strict regulation. The proliferation and differentiation of myoblasts are important factors determining chicken muscle development. Circular RNAs (circRNAs) are endogenous RNAs that are widely present in various tissues of organisms. Recent studies have shown that circRNA plays key roles in the development of skeletal muscles. The solute carrier (SLC) family functions in the transport of metabolites such as amino acids, glucose, nucleotides, and essential nutrients and is widely involved in various basic physiological metabolic processes within the body. In this study, we have cloned a novel chicken circular RNA circSLC2A13 generated from the solute carrier family 2 member 13 gene (SLC2A13). Also, circSLC2A1 was confirmed by sequencing verification, RNase R treatment, and reverse transcription analysis. Currently, our results show that circSLC2A13 promoted the proliferation and differentiation of chicken myoblasts. The double luciferase reporter system revealed that circSLC2A13 regulated the proliferation and differentiation of myoblasts by competitive binding with miR-34a-3p. In addition, results indicated that circSLC2A13 acts as a miR-34a-3p sponge to relieve its inhibitory effect on the target SMAD3 gene. In summary, this study found that chicken circSLC2A13 can bind to miR-34a-3p and weaken its inhibitory effect on the SMAD family member 3 gene (SMAD3), thereby promoting the proliferation and differentiation of myoblasts. This study laid foundations for broiler industry and muscle development research.
Sujet(s)
Différenciation cellulaire , Prolifération cellulaire , Poulets , microARN , Développement musculaire , Muscles squelettiques , Myoblastes , ARN circulaire , Animaux , microARN/génétique , microARN/métabolisme , ARN circulaire/génétique , ARN circulaire/métabolisme , Poulets/génétique , Poulets/croissance et développement , Poulets/métabolisme , Développement musculaire/génétique , Muscles squelettiques/métabolisme , Muscles squelettiques/croissance et développement , Myoblastes/métabolisme , Myoblastes/cytologieRÉSUMÉ
Skeletal muscle regeneration involves a signaling network that regulates the proliferation, differentiation, and fusion of muscle precursor cells to injured myofibers. IRE1α, one of the arms of the unfolded protein response, regulates cellular proteostasis in response to ER stress. Here, we demonstrate that inducible deletion of IRE1α in satellite cells of mice impairs skeletal muscle regeneration through inhibiting myoblast fusion. Knockdown of IRE1α or its downstream target, X-box protein 1 (XBP1), also inhibits myoblast fusion during myogenesis. Transcriptome analysis revealed that knockdown of IRE1α or XBP1 dysregulates the gene expression of molecules involved in myoblast fusion. The IRE1α-XBP1 axis mediates the gene expression of multiple profusion molecules, including myomaker (Mymk). Spliced XBP1 (sXBP1) transcription factor binds to the promoter of Mymk gene during myogenesis. Overexpression of myomaker in IRE1α-knockdown cultures rescues fusion defects. Inducible deletion of IRE1α in satellite cells also inhibits myoblast fusion and myofiber hypertrophy in response to functional overload. Collectively, our study demonstrates that IRE1α promotes myoblast fusion through sXBP1-mediated up-regulation of the gene expression of multiple profusion molecules, including myomaker.
Sujet(s)
Fusion cellulaire , Endoribonucleases , Développement musculaire , Muscles squelettiques , Myoblastes , Protein-Serine-Threonine Kinases , Transduction du signal , Protéine-1 liant la boite X , Animaux , Protéine-1 liant la boite X/métabolisme , Protéine-1 liant la boite X/génétique , Protein-Serine-Threonine Kinases/métabolisme , Protein-Serine-Threonine Kinases/génétique , Souris , Myoblastes/métabolisme , Myoblastes/cytologie , Muscles squelettiques/métabolisme , Muscles squelettiques/cytologie , Développement musculaire/génétique , Endoribonucleases/métabolisme , Endoribonucleases/génétique , Cellules satellites du muscle squelettique/métabolisme , Régénération/génétique , Différenciation cellulaire/génétique , Régulation de l'expression des gènes , Protéines membranaires , Protéines du muscleRÉSUMÉ
Sarcopenia is a common complication of chronic kidney disease (CKD) and has a detrimental effect on prognosis. Previous studies have explored the role of secondary calciprotein particles (CPP2) in determining the progression of complications and poor outcomes in patients with CKD. However, no study has demonstrated that CPP2 impairs skeletal myogenesis. Our study revealed that CPP2 exposure inhibits skeletal myogenesis by suppressing myotube formation and expression of skeletal muscle-specific myosin heavy chain and actin in human primary myoblasts. Moreover, CPP2 exposure altered the expression patterns of lineage-determinative transcription factors responsible for regulating myotube differentiation marker genes. This study first demonstrated that CPP2 interferes with myoblast differentiation and myotube formation in vitro.
Sujet(s)
Différenciation cellulaire , Développement musculaire , Myoblastes , Humains , Myoblastes/métabolisme , Myoblastes/cytologie , Cellules cultivées , Fibres musculaires squelettiques/métabolisme , Muscles squelettiques/métabolisme , Muscles squelettiques/cytologie , Chaînes lourdes de myosine/métabolisme , Chaînes lourdes de myosine/génétique , Régulation de l'expression des gènesRÉSUMÉ
Muscle development is a multistep process regulated by diverse gene networks, and circRNAs are considered novel regulators mediating myogenesis. Here, we systematically analyzed the role and underlying regulatory mechanisms of circRBBP7 in myoblast proliferation and differentiation. Results showed that circRBBP7 has a typical circular structure and encodes a 13 -kDa protein. By performing circRBBP7 overexpression and RNA interference, we found that the function of circRBBP7 was positively correlated with the proliferation and differentiation of myoblasts. Using RNA sequencing, we identified 1633 and 532 differentially expressed genes (DEGs) during myoblast proliferation or differentiation, respectively. The DEGs were found mainly enriched in cell cycle- and skeletal muscle development-related pathways, such as the MDM2/p53 and PI3K-Akt signaling pathways. Further co-IP and IF co-localization analysis revealed that VEGFR-1 is a target of circRBBP7 in myoblasts. qRT-PCR and WB analysis further confirmed the positive correlation between VEGFR-1 and circRBBP7. Moreover, we found that in vivo transfection of circRBBP7 into injured muscle tissues significantly promoted the regeneration and repair of myofibers in mice. Therefore, we speculate that circRBBP7 may affect the activity of MDM2 by targeting VEGFR-1, altering the expression of muscle development-related genes by mediating p53 degradation, and ultimately promoting myoblast development and muscle regeneration. This study provides essential evidence that circRBBP7 can serve as a potential target for myogenesis regulation and a reference for the application of circRBBP7 in cattle genetic breeding and muscle injury treatment.
Sujet(s)
Différenciation cellulaire , Prolifération cellulaire , Développement musculaire , Myoblastes , ARN circulaire , Animaux , Mâle , Souris , Lignée cellulaire , Souris de lignée C57BL , Développement musculaire/physiologie , Muscles squelettiques/métabolisme , Muscles squelettiques/cytologie , Myoblastes/métabolisme , Myoblastes/cytologie , Protéines proto-oncogènes c-mdm2/métabolisme , Protéines proto-oncogènes c-mdm2/génétique , ARN circulaire/génétique , ARN circulaire/métabolisme , Transduction du signal , Protéine p53 suppresseur de tumeur/métabolisme , Protéine p53 suppresseur de tumeur/génétiqueRÉSUMÉ
Skeletal muscle function is highly dependent on the energy supply provided by mitochondria. Besides ATP production, mitochondria have several other roles, such as calcium storage, heat production, cell death signaling, autophagy regulation and redox state modulation. Mitochondrial function is crucial for skeletal muscle fiber formation. Disorders that affect mitochondria have a major impact in muscle development and function. Here we studied the role of mitochondria during chick skeletal myogenesis. We analyzed the intracellular distribution of mitochondria in myoblasts, fibroblasts and myotubes using Mitotracker labeling. Mitochondrial respiration was investigated in chick muscle cells. Our results show that (i) myoblasts and myotubes have more mitochondria than muscle fibroblasts; (ii) mitochondria are organized in long lines within the whole cytoplasm and around the nuclei of myotubes, while in myoblasts they are dispersed in the cytoplasm; (iii) the area of mitochondria in myotubes increases during myogenesis, while in myoblasts and fibroblasts there is a slight decrease; (iv) mitochondrial length increases in the three cell types (myoblasts, fibroblasts and myotubes) during myogenesis; (v) the distance of mitochondria to the nucleus increases in myoblasts and myotubes during myogenesis; (vi) Rotenone inhibits muscle fiber formation, while FCCP increases the size of myotubes; (vii) N-acetyl cysteine (NAC), an inhibitor of ROS formation, rescues the effects of Rotenone on muscle fiber size; and (viii) Rotenone induces the production of ROS in chick myogenic cells. The collection of our results suggests a role of ROS signaling in mitochondrial function during chick myogenesis.
Sujet(s)
Développement musculaire , Fibres musculaires squelettiques , Myoblastes , Espèces réactives de l'oxygène , Roténone , Animaux , Espèces réactives de l'oxygène/métabolisme , Développement musculaire/effets des médicaments et des substances chimiques , Embryon de poulet , Roténone/pharmacologie , Fibres musculaires squelettiques/métabolisme , Fibres musculaires squelettiques/effets des médicaments et des substances chimiques , Fibres musculaires squelettiques/cytologie , Myoblastes/métabolisme , Myoblastes/effets des médicaments et des substances chimiques , Myoblastes/cytologie , Fibroblastes/métabolisme , Fibroblastes/effets des médicaments et des substances chimiques , Mitochondries/métabolisme , Mitochondries/effets des médicaments et des substances chimiquesRÉSUMÉ
Pyruvate kinase is a glycolytic enzyme that converts phosphoenolpyruvate and ADP into pyruvate and ATP. There are two genes that encode pyruvate kinase in vertebrates; Pkm and Pkl encode muscle- and liver/erythrocyte-specific forms, respectively. Each gene encodes two isoenzymes due to alternative splicing. Both muscle-specific enzymes, PKM1 and PKM2, function in glycolysis, but PKM2 also has been implicated in gene regulation due to its ability to phosphorylate histone 3 threonine 11 (H3T11) in cancer cells. Here, we examined the roles of PKM1 and PKM2 during myoblast differentiation. RNA-seq analysis revealed that PKM2 promotes the expression of Dpf2/Baf45d and Baf250a/Arid1A. DPF2 and BAF250a are subunits that identify a specific sub-family of the mammalian SWI/SNF (mSWI/SNF) of chromatin remodeling enzymes that is required for the activation of myogenic gene expression during differentiation. PKM2 also mediated the incorporation of DPF2 and BAF250a into the regulatory sequences controlling myogenic gene expression. PKM1 did not affect expression but was required for nuclear localization of DPF2. Additionally, PKM2 was required not only for the incorporation of phosphorylated H3T11 in myogenic promoters but also for the incorporation of phosphorylated H3T6 and H3T45 at myogenic promoters via regulation of AKT and protein kinase C isoforms that phosphorylate those amino acids. Our results identify multiple unique roles for PKM2 and a novel function for PKM1 in gene expression and chromatin regulation during myoblast differentiation.
Sujet(s)
Différenciation cellulaire , Histone , Myoblastes , Pyruvate kinase , Animaux , Pyruvate kinase/métabolisme , Pyruvate kinase/génétique , Souris , Phosphorylation , Histone/métabolisme , Histone/génétique , Myoblastes/métabolisme , Myoblastes/cytologie , Facteurs de transcription/métabolisme , Facteurs de transcription/génétique , , Humains , Protéines chromosomiques nonhistones/métabolisme , Protéines chromosomiques nonhistones/génétique , Hormones thyroïdiennes/métabolisme , Hormones thyroïdiennes/génétique , Protéines de liaison à l'ADN/métabolisme , Protéines de liaison à l'ADN/génétique , Isoenzymes/métabolisme , Isoenzymes/génétiqueRÉSUMÉ
Fibroblast growth factor receptors (Fgfrs) are involved in cell proliferation, differentiation, and migration via complex signaling pathways in different tissues. Our previous studies showed that fibroblast growth factor receptor 4 (fgfr4) was detected in the most significant quantitative trait loci (QTL) for growth traits. However, studies focusing on the function of fgfr4 on the growth of bony fish are still limited. In this study, we identified seven fgfr genes in spotted sea bass (Lateolabrax maculatus) genome, namely fgfr1a, fgfr1b, fgfr2, fgfr3, fgfr4, fgfr5a, and fgfr5b. Phylogenetic analysis, syntenic analysis and gene structure analysis were conducted to further support the accuracy of our annotation and classification results. Additionally, fgfr4 showed the highest expression levels among fgfrs during the proliferation and differentiation stages of spotted sea bass myoblasts. To further study the function of fgfr4 in myogenesis, dual-fluorescence in situ hybridization (ISH) assay was conducted, and the results showed co-localization of fgfr4 with marker gene of skeletal muscle satellite cells. By treating differentiating myoblasts cultured in vitro with BLU-554, the mRNA expressions of myogenin (myog) and the numbers of myotubes formed by myoblasts increased significantly compared to negative control group. These results indicated that Fgfr4 inhibits the differentiation of myoblasts in spotted sea bass. Our findings contributed to filling a research gap on fgfr4 in bony fish myogenesis and the theoretical understanding of growth trait regulation of spotted sea bass.
Sujet(s)
Serran , Différenciation cellulaire , Phylogenèse , Récepteur FGFR4 , Animaux , Récepteur FGFR4/génétique , Récepteur FGFR4/métabolisme , Différenciation cellulaire/génétique , Serran/génétique , Serran/métabolisme , Myoblastes/métabolisme , Myoblastes/cytologie , Développement musculaire/génétique , Protéines de poisson/génétique , Protéines de poisson/métabolisme , Prolifération cellulaireRÉSUMÉ
Dasatinib is one of the second-generation tyrosine kinase inhibitors used to treat chronic myeloid leukemia and has a broad target spectrum, including KIT, PDGFR, and SRC family kinases. Due to its broad drug spectrum, dasatinib has been reported at the basic research level to improve athletic performance by eliminating senescent cell removal and to have an effect on muscle diseases such as Duchenne muscular dystrophy, but its effect on myoblasts has not been investigated. In this study, we evaluated the effects of dasatinib on skeletal muscle both under normal conditions and in the regenerating state. Dasatinib suppressed the proliferation and promoted the fusion of C2C12 myoblasts. During muscle regeneration, dasatinib increased the gene expressions of myogenic-related genes (Myod, Myog, and Mymx), and caused abnormally thin muscle fibers on the CTX-induced muscle injury mouse model. From these results, dasatinib changes the closely regulated gene expression pattern of myogenic regulatory factors during muscle differentiation and disrupts normal muscle regeneration. Our data suggest that when using dasatinib, its effects on skeletal muscle should be considered, particularly at regenerating stages.
Sujet(s)
Différenciation cellulaire , Dasatinib , Développement musculaire , Muscles squelettiques , Myoblastes , Régénération , Dasatinib/pharmacologie , Animaux , Souris , Régénération/effets des médicaments et des substances chimiques , Différenciation cellulaire/effets des médicaments et des substances chimiques , Développement musculaire/effets des médicaments et des substances chimiques , Développement musculaire/génétique , Muscles squelettiques/effets des médicaments et des substances chimiques , Myoblastes/effets des médicaments et des substances chimiques , Myoblastes/métabolisme , Myoblastes/cytologie , Prolifération cellulaire/effets des médicaments et des substances chimiques , Humains , Lignée cellulaire , Inhibiteurs de protéines kinases/pharmacologieRÉSUMÉ
As cellular transcription factors and DNA replicators, nuclear factor I (NFI) family members play an important role in mammalian development. However, there is still a lack of research on the muscle regeneration of NFI family members in cattle. In this study, the analysis of NFI family factors was conducted on their characterization, phylogenetics, and functional domains. We found that NFI family members were relatively conserved among different species, but there was heterogeneity in amino acid sequences, DNA coding sequences, and functional domain among members. Furthermore, among NFI family factors, we observed that NFIC exhibited highly expression in bovine muscle tissues, particularly influencing the expression of proliferation marker genes in myoblasts. To investigate the influence of NFIC on myoblast proliferation, we knocked down NFIC (si-NFIC) and found that the proliferation of myoblasts was significantly promoted. In terms of regulation mechanism, we identified that si-NFIC could counteract the inhibitory effect of the cell cycle inhibitor RO-3306. Interestingly, CENPF, as the downstream target gene of NFIC, could affect the expression of CDK1, CCNB1, and actively regulate the cell cycle pathway and cell proliferation. In addition, when CENPF was knocked down, the phosphorylation of p53 and the expression of Bax were increased, but the expression of Bcl2 was inhibited. Our findings mainly highlight the mechanism by which NFIC acts on the CENPF/CDK1 axis to regulate the proliferation of bovine myoblasts.
Sujet(s)
Protéine-kinase CDC2 , Prolifération cellulaire , Myoblastes , Facteurs nucléaires-I , Animaux , Bovins , Myoblastes/métabolisme , Myoblastes/cytologie , Protéine-kinase CDC2/métabolisme , Protéine-kinase CDC2/génétique , Facteurs nucléaires-I/génétique , Facteurs nucléaires-I/métabolisme , Techniques de knock-down de gènes , Cycle cellulaireRÉSUMÉ
Cultured meat technology is expected to solve problems such as resource shortages and environmental pollution, but the muscle fiber differentiation efficiency of cultured meat is low. Genipin is the active compound derived from Gardenia jasminoides Ellis, which has a variety of activities. Additionally, genipin serves as a noncytotoxic agent for cross-linking, which is suitable as a foundational scaffold for in vitro tissue regeneration. However, the impact of genipin on myoblast differentiation remains to be studied. The research revealed that genipin was found to improve the differentiation efficiency of myoblasts. Genipin improved mitochondrial membrane potential by activating the AMPK signaling pathway of myoblasts, promoting mitochondrial biogenesis, and mitochondrial network remodeling. Genipin activated autophagy in myoblasts and maintained cellular homeostasis. Autophagy inhibitors blocked the pro-differentiation effect of genipin. These results showed that genipin improved the differentiation efficiency of myoblasts, which provided a theoretical basis for the development of cultured meat technology.
Sujet(s)
AMP-Activated Protein Kinases , Autophagie , Différenciation cellulaire , Iridoïdes , Myoblastes , Transduction du signal , Iridoïdes/pharmacologie , Iridoïdes/composition chimique , Différenciation cellulaire/effets des médicaments et des substances chimiques , Myoblastes/effets des médicaments et des substances chimiques , Myoblastes/cytologie , Myoblastes/métabolisme , Autophagie/effets des médicaments et des substances chimiques , AMP-Activated Protein Kinases/métabolisme , AMP-Activated Protein Kinases/génétique , Animaux , Souris , Transduction du signal/effets des médicaments et des substances chimiques , Lignée cellulaire , HumainsRÉSUMÉ
Ubiquitin-conjugation enzyme E2C (UBE2C) is a crucial component of the ubiquitin-proteasome system that is involved in numerous cancers. In this study, we find that UBE2C expression is significantly increased in mouse embryos, a critical stage during skeletal muscle development. We further investigate the function of UBE2C in myogenesis. Knockdown of UBE2C inhibits C2C12 cell differentiation and decreases the expressions of MyoG and MyHC, while overexpression of UBE2C promotes C2C12 cell differentiation. Additionally, knockdown of UBE2C, specifically in the tibialis anterior muscle (TA), severely impedes muscle regeneration in vivo. Mechanistically, we show that UBE2C knockdown reduces the level of phosphorylated protein kinase B (p-Akt) and promotes the degradation of Akt. These findings suggest that UBE2C plays a critical role in myoblast differentiation and muscle regeneration and that UBE2C regulates myogenesis through the Akt signaling pathway.
Sujet(s)
Différenciation cellulaire , Développement musculaire , Muscles squelettiques , Myoblastes , Protéines proto-oncogènes c-akt , Régénération , Transduction du signal , Ubiquitin-conjugating enzymes , Animaux , Muscles squelettiques/métabolisme , Muscles squelettiques/cytologie , Ubiquitin-conjugating enzymes/métabolisme , Ubiquitin-conjugating enzymes/génétique , Protéines proto-oncogènes c-akt/métabolisme , Protéines proto-oncogènes c-akt/génétique , Régénération/génétique , Myoblastes/métabolisme , Myoblastes/cytologie , Souris , Développement musculaire/génétique , Lignée cellulaireRÉSUMÉ
The presence of nuclear architectural abnormalities is a hallmark of the nuclear envelopathies, which are a group of diseases caused by mutations in genes encoding nuclear envelope proteins. Mutations in the lamin A/C gene cause several diseases, named laminopathies, including muscular dystrophies, progeria syndromes, and lipodystrophy. A mouse model carrying with the LmnaH222P/H222P mutation (H222P) was shown to develop severe cardiomyopathy but only mild skeletal myopathy, although abnormal nuclei were observed in their striated muscle. In this report, we analyzed the abnormal-shaped nuclei in myoblasts and myotubes isolated from skeletal muscle of H222P mice, and evaluated the expression of nuclear envelope proteins in these abnormal myonuclei. Primary skeletal muscle cells from H222P mice proliferated and efficiently differentiated into myotubes in vitro, similarly to those from wild-type mice. During cell proliferation, few abnormal-shaped nuclei were detected; however, numerous markedly abnormal myonuclei were observed in myotubes from H222P mice on days 5 and 7 of differentiation. Time-lapse observation demonstrated that myonuclei with a normal shape maintained their normal shape, whereas abnormal-shaped myonuclei remained abnormal for at least 48 h during differentiation. Among the abnormal-shaped myonuclei, 65% had a bleb with a string structure, and 35% were severely deformed. The area and nuclear contents of the nuclear blebs were relatively stable, whereas the myocytes with nuclear blebs were actively fused within primary myotubes. Although myonuclei were markedly deformed, the deposition of DNA damage marker (γH2AX) or apoptotic marker staining was rarely observed. Localizations of lamin A/C and emerin were maintained within the blebs, strings, and severely deformed regions of myonuclei; however, lamin B1, nesprin-1, and a nuclear pore complex protein were absent in these abnormal regions. These results demonstrate that nuclear membranes from H222P skeletal muscle cells do not rupture and are resistant to DNA damage, despite these marked morphological changes.
Sujet(s)
Différenciation cellulaire , Noyau de la cellule , Lamine A , Fibres musculaires squelettiques , Animaux , Fibres musculaires squelettiques/anatomopathologie , Fibres musculaires squelettiques/métabolisme , Fibres musculaires squelettiques/cytologie , Lamine A/génétique , Lamine A/métabolisme , Noyau de la cellule/métabolisme , Souris , Prolifération cellulaire , Protéines nucléaires/métabolisme , Protéines nucléaires/génétique , Myoblastes/métabolisme , Myoblastes/anatomopathologie , Myoblastes/cytologie , Muscles squelettiques/anatomopathologie , Muscles squelettiques/cytologie , Muscles squelettiques/métabolismeRÉSUMÉ
Myoblast proliferation and differentiation are essential for skeletal muscle development. In this study, we generated the expression profiles of mRNAs, long noncoding RNAs (lncRNAs), and microRNAs (miRNAs) in different developmental stages of chicken primary myoblasts (CPMs) using RNA sequencing (RNA-seq) technology. The dual luciferase reporter system was performed using chicken embryonic fibroblast cells (DF-1), and functional studies quantitative real-time polymerase chain reaction (qPCR), cell counting kit-8 (CCK-8), 5-Ethynyl-2'-deoxyuridine (EdU), flow cytometry cycle, RNA fluorescence in situ hybridization (RNA-FISH), immunofluorescence, and western blotting assay. Our research demonstrated that miR-301a-5p had a targeted binding ability to lncMDP1 and ChaC glutathione-specific gamma-glutamylcyclotransferase 1 (CHAC1). The results revealed that lncMDP1 regulated the proliferation and differentiation of myoblasts via regulating the miR-301a-5p/CHAC1 axis, and CHAC1 promotes muscle regeneration. This study fulfilled the molecular regulatory network of skeletal muscle development and providing an important theoretical reference for the future improvement of chicken meat performance and meat quality.
Sujet(s)
Poulets , Analyse de profil d'expression de gènes , microARN , Développement musculaire , ARN long non codant , Animaux , microARN/génétique , microARN/métabolisme , Développement musculaire/génétique , Poulets/génétique , ARN long non codant/génétique , ARN long non codant/métabolisme , Différenciation cellulaire/génétique , Prolifération cellulaire , Myoblastes/métabolisme , Myoblastes/cytologie , Embryon de pouletRÉSUMÉ
Myogenesis is regulated mainly by transcription factors known as Myogenic Regulatory Factors (MRFs), and the transcription is affected by epigenetic modifications. However, the epigenetic regulation of myogenesis is poorly understood. Here, we focused on the epigenomic modification enzyme, PHF2, which demethylates histone 3 lysine 9 dimethyl (H3K9me2) during myogenesis. Phf2 mRNA was expressed during myogenesis, and PHF2 was localized in the nuclei of myoblasts and myotubes. We generated Phf2 knockout C2C12 myoblasts using the CRISPR/Cas9 system and analyzed global transcriptional changes via RNA-sequencing. Phf2 knockout (KO) cells 2 d post differentiation were subjected to RNA sequencing. Gene ontology (GO) analysis revealed that Phf2 KO impaired the expression of the genes related to skeletal muscle fiber formation and muscle cell development. The expression levels of sarcomeric genes such as Myhs and Mybpc2 were severely reduced in Phf2 KO cells at 7 d post differentiation, and H3K9me2 modification of Mybpc2, Mef2c and Myh7 was increased in Phf2 KO cells at 4 d post differentiation. These findings suggest that PHF2 regulates sarcomeric gene expression via epigenetic modification.
Sujet(s)
Développement musculaire , Sarcomères , Animaux , Souris , Différenciation cellulaire/génétique , Lignée cellulaire , Épigenèse génétique , Techniques de knock-out de gènes , Histone Demethylases/métabolisme , Histone Demethylases/génétique , Histone/métabolisme , Facteurs de transcription MEF2/génétique , Facteurs de transcription MEF2/métabolisme , Développement musculaire/génétique , Fibres musculaires squelettiques/métabolisme , Fibres musculaires squelettiques/cytologie , Myoblastes/métabolisme , Myoblastes/cytologie , Chaînes lourdes de myosine/génétique , Chaînes lourdes de myosine/métabolisme , Sarcomères/métabolisme , Facteurs de transcription/métabolisme , Facteurs de transcription/génétique , Transcription génétiqueRÉSUMÉ
Tropomyosin 3 (TPM3) plays a significant role as a regulatory protein in muscle contraction, affecting the growth and development of skeletal muscles. Despite its importance, limited research has been conducted to investigate the influence of TPM3 on bovine skeletal muscle development. Therefore, this study revealed the role of TPM3 in bovine myoblast growth and development. This research involved conducting a thorough examination of the Qinchuan cattle TPM3 gene using bioinformatics tools to examine its sequence and structural characteristics. Furthermore, TPM3 expression was evaluated in various bovine tissues and cells using quantitative real-time polymerase chain reaction (qRT-PCR). The results showed that the coding region of TPM3 spans 855 bp, with the 161st base being the T base, encoding a protein with 284 amino acids and 19 phosphorylation sites. This protein demonstrated high conservation across species while displaying a predominant α-helix secondary structure despite being an unstable acidic protein. Notably, a noticeable increase in TPM3 expression was observed in the longissimus dorsi muscle and myocardium of calves and adult cattle. Expression patterns varied during different stages of myoblast differentiation. Functional studies that involved interference with TPM3 in Qinchuan cattle myoblasts revealed a very significantly decrease in S-phase cell numbers and EdU-positive staining (P < 0.01), and disrupted myotube morphology. Moreover, interference with TPM3 resulted in significantly (P < 0.05) or highly significantly (P < 0.01) decreased mRNA and protein levels of key proliferation and differentiation markers, indicating its role in the modulation of myoblast behavior. These findings suggest that TPM3 plays an essential role in bovine skeletal muscle growth by influencing myoblast proliferation and differentiation. This study provides a foundation for further exploration into the mechanisms underlying TPM3-mediated regulation of bovine muscle development and provides valuable insights that could guide future research directions as well as potential applications for livestock breeding and addressing muscle-related disorders.